Great observation Coads!, The smaller DurAVR valve as ~22mm outperforms larger sized competitor valves (29mm and 31mm), imagine how a 31mm DurAVR would perform! If we can make these for small difficult annuluses then the larger ones should be no problem.
Don't forget the the current valves in the market are suffering from poor durability, most likely DURAVR will be the valve of choice for ViV replacement IMO.
Bodes well for partnership before Pivotal trial? Or will ViV near term revenue opportunity allow us to go it alone?
Sitting on both hands.
Ann: Updated 30-day DurAVR THV Clinical Data, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.00 |
Change
-0.030(0.50%) |
Mkt cap ! $92.99M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.03 | $5.84 | $85.53K | 14.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 333 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.25 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |